PTCT Ptc Therapeutics Earnings and EPS analysis

  1. Stocks
  2. Healthcare
  3. NASDAQ: PTCT
  4. Earnings
?
Relative Growth: Rel. Growth: 24
Relative Strength: Rel. Strength: 76
Relative Valuation: Rel. Valuation: 10
Relative Profitability: Rel. Profitability: 25

EPS in 2026 (TTM): -$2.48

Last Report Period Date: Mar 31, 2026

Based on the company's latest reports for March 2026, the EPS for the trailing twelve months is -$2.48. Ptc Therapeutics's earnings per share in 2025 amounted to $8.58, marking an increase from -$4.73 in 2024. During the quarterly period ending on Mar 31, 2026, PTCT's earnings per share stood at -$0.03.

PTCT earnings history

Historical annual and quarterly earnings per share (EPS) data for Ptc Therapeutics
EPS (TTM)
-$2.48
EPS Growth YoY (Quarterly)
-100.3%
EPS (Quarterly)
-$0.03
EPS Growth (Quarterly)
98.4%

Ptc Therapeutics had an yealy EPS of $8.58, indicating an increase of 281.4% from -$4.73 recorded in 2024. The quarterly per-share earnings for the period ending Mar 31, 2026, was -$0.03, indicating a 100.3% decline compared to the same quarter last year. PTCT's 12-month EPS is -$2.48 as of March 2026. Ptc Therapeutics's annual EPS in 2024 was -$4.73, a 43.5% rise year-over-year.

PTCT earnings chart

PTCT EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
-100.3%
EPS growth YoY
281.4%
EPS growth 3Y avg
N/A
EPS growth 5Y avg
N/A

Over the past 12 months, Ptc Therapeutics has recorded an earnings per share growth of -100.3% (YoY, quarterly).

PTCT Earnings Waterfall

Breakdown of revenue, profit and net income for Ptc Therapeutics

PTCT Earnings vs Peers

What are the earnings of PTCT compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
NVS Novartis AG 21.85 21.8% 31.2% 15.2%
VRTX Vertex Pharmaceuticals Inc 27.54 843.3% 6% 8.2%
SRPT Sarepta Therapeutics Inc 28.77 -388.7% N/A N/A
FATE Fate Therapeutics Inc N/A 29.9% N/A N/A
XNCR Xencor Inc N/A 65.4% N/A N/A
PTCT Ptc Therapeutics Inc N/A 281.4% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.